(CAMBRIDGE, Mass.)Biotechnology company ImmunoGen Inc. said Thursday it promoted Daniel M. Junius to the new position of president and chief operating officer. Junius, 55, has been an executive vice...READ MORE
(NEW YORK)Analysts said Celgene Corp. and Genentech Inc. are their top picks heading into the 44th annual American Society of Clinical Oncology meeting, or ASCO, taking place May 30 to June ...READ MORE
(NEW YORK)Immunogen and Biotest are asking for government approval of a new cancer-fighting drug. The drug, called BT-062, is said to be able to stick to certain kinds of cancer cells and de...READ MORE
(CAMBRIDGE, Mass.)ImmunoGen Inc. said Friday it will receive a $1.5 million payment after its partner Biogen Idec Inc. asked the Food and Drug Administration to approve studies on an experimental an...READ MORE
(CAMBRIDGE, Mass.)Biotechnology company ImmunoGen Inc. said Thursday it licensed an experimental cancer treatment from Johnson & Johnson's Centocor unit. Under the deal, ImmunoGen gains the exclusiv...READ MORE
(NEW YORK)Lazard Capital Markets said Wednesday rising demand for new medical treatments will continue to drive earnings growth in the biotechnology sector in 2008, providing attractive oppo...READ MORE